Dr Belinda Yeo
“I am a passionate clinician. My research focuses on trying to find better ways to estimate recurrence risk in patients with breast cancer in order to personalise our therapies to those who have the most to gain from them."
Dr Belinda Yeo (FRACP, MD, MBBS, BA)
Belinda Yeo is jointly appointed to the Austin Hospital in Melbourne, Australia, as a Medical Oncologist and to the Olivia Newton-John Cancer Research Institute as a Clinician Scientist with a specific interest in breast cancer.
She trained in Sydney before joining the Breast Unit at The Royal Marsden Hospital, London as a Clinical and Research Fellow. She completed a Master’s Degree at The University of London and The Institute of Cancer Research in novel genomic and non-molecular breast cancer risk assays.
She is co-lead of the VCCC Research and Education of the Breast Tumour Stream, she is a clinical trial investigator and continues her translational research investigating improving personalisation and minimising toxicities for patients with breast cancer.
MD Institute of Cancer Research, University of London, UK, 2016.
FRACP Royal Australasian College of Physicians, 2014.
MBBS University of Sydney, Australia, 2004.
BA University of Sydney, Australia, 2000.
Medical Oncologist, ONJ Centre, Austin Health, Melbourne.
Clinician Scientist, Olivia Newton-John Cancer Research Institute, Melbourne.
Honorary Associate, School of Cancer Medicine, La Trobe University, Melbourne.
Darebin St Specialist Centre
66 Darebin St, Heidelberg, 3084
Ph: 9458 5100 Fax: 9458 5199